Comments
Loading...
Candel Therapeutics (CADL) Forecast
NewsEarningsCandel Therapeutics (CADL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCandel Therapeutics (NASDAQ:CADL) Stock Quotes, Forecast and News Summary
Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Candel Therapeutics (CADL) stock?
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Who are Candel Therapeutics (CADL) competitors?
Other companies in Candel Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN) and Precigen (NASDAQ:PGEN).
What is the forecast, or price target, for Candel Therapeutics (CADL) stock?
Candel Therapeutics has a consensus price target of $14.43.
What is the current price for Candel Therapeutics (CADL)?
The stock price for Candel Therapeutics (NASDAQ: CADL) is $11.14 last updated February 24, 2025 at 11:25 AM EST.
Does Candel Therapeutics (CADL) pay a dividend?
There are no upcoming dividends for Candel Therapeutics.
When is Candel Therapeutics (NASDAQ:CADL) reporting earnings?
Candel Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Candel Therapeutics (CADL) going to split?
There is no upcoming split for Candel Therapeutics.
What sector and industry does Candel Therapeutics (CADL) operate in?
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.